Anti-Factor X antibody [EPR16249]
- RabMAb
- Recombinant
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(2 제품이 사용된 논문 )
Rabbit Recombinant Monoclonal Factor X antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 2 publications.
대체 명칭 보기
Coagulation factor X, Stuart factor, Stuart-Prower factor, F10
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Factor X antibody [EPR16249] (AB196023)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling Factor X with ab196023 at 1/1200 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Cytoplasm staining on Human liver tissue is observed. Counter stained with Hematoxylin.
Secondary control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-Factor X antibody [EPR16249] (AB196023)
Blocking/Dilution buffer : 5% NFDM/TBST.
We hypothesis the 74 kDa band is the precursor of Factor X.
Factor X contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted. This is consistent with what has been seen in PMID : 19691479.
All lanes:
Western blot - Anti-Factor X antibody [EPR16249] (ab196023) at 1/20000 dilution
All lanes:
HepG2 (Human liver hepatocellular carcinoma) cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 54 kDa
Observed band size: 74 kDa
false
- WB
Supplier Data
Western blot - Anti-Factor X antibody [EPR16249] (AB196023)
Blocking/Dilution buffer : 5% NFDM/TBST.
We hypothesis the 74 kDa band is the precursor of Factor X.
Factor X contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted. This is consistent with what has been seen in PMID : 19691479.
All lanes:
Western blot - Anti-Factor X antibody [EPR16249] (ab196023) at 1/20000 dilution
All lanes:
Human plasma lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 54 kDa
Observed band size: 74 kDa
false
- WB
Supplier Data
Western blot - Anti-Factor X antibody [EPR16249] (AB196023)
Blocking/Dilution buffer : 5% NFDM/TBST.
We hypothesis the 74 kDa band is the precursor of Factor X.
Factor X contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted. This is consistent with what has been seen in PMID : 19691479.
All lanes:
Western blot - Anti-Factor X antibody [EPR16249] (ab196023) at 1/20000 dilution
Lane 1:
Human fetal liver lysate at 10 µg
Lane 2:
Human blood lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 54 kDa
Observed band size: 74 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-Factor X antibody [EPR16249] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Factor X contributes significantly to the coagulation process by activating prothrombin into thrombin. It is not part of a larger complex but functions closely with other components of the coagulation cascade to maintain hemostasis. Factor X interacts with calcium ions and phospholipids on the surface of platelets enhancing its enzymatic activity. This activation ensures proper regulation of blood clotting preventing excessive bleeding or uncontrolled clot formation.
Pathways
Factor X is central to both the intrinsic and extrinsic coagulation pathways. It interacts with proteins such as factor VIIa in the extrinsic pathway and factor IXa in the intrinsic pathway both pathways leading to the activation of factor Xa. In turn factor Xa is key in the common pathway which combines inputs from the intrinsic and extrinsic pathways to produce thrombin essential for fibrin clot formation.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (2)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Cancer research 83:3920-3939 PubMed37729394
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 15:e17376 PubMed37534622
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com